ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Neurology

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

11,216Medicare Part D Prescriptions Filled, Including Refills

Rank: 3 out of 491

$1.69M Total Retail Price of All Prescriptions

Rank: 9 out of 491

953 Patients Receiving at Least One Drug in Part D
48%Patients 65 Years and Older
66% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Texas
Lower avg

Schedule Two
Controlled Substances

12% of this provider’s 953 patients filled at least one prescription for a schedule two drug, compared to an average of 2%.

Schedule Three
Controlled Substances

44% of this provider’s 953 patients filled at least one prescription for a schedule three drug, compared to an average of 5%.

Risky Drugs to Seniors

7% of this provider’s 4,205 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

15% of this provider’s prescriptions were for brand-name drugs, compared to an average of 28%.

Prescription Price

$151 was the average price of a prescription from this provider, compared to $218 among peers.

Prescriptions per Patient

12 is the average number of prescriptions (including refills) per patient, compared to an average of 9.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Texas
HYDROCODONE-ACETAMINOPHEN 2,701 981 S3 1 6
CARISOPRODOL 485 93 R 2 24
GABAPENTIN 456 195 3 1
LEVETIRACETAM 452 222 4 5
MELOXICAM 408 198 5 37
ZOLPIDEM TARTRATE 245 89 6 28
TOPIRAMATE 243 58 7 7
LAMOTRIGINE 237 47 8 8
LYRICA 222 90 9 10
METHADONE HCL 208 47 S2 10 54
TRAMADOL HCL 204 72 11 27
FENTANYL 194 56 S2 12 50
MORPHINE SULFATE ER 193 15 S2 13 45
PREDNISONE 192 101 14 46
CITALOPRAM HBR 173 73 15 18
ZONISAMIDE 169 47 16 22
DONEPEZIL HCL 162 150 17 3
CYCLOBENZAPRINE HCL 160 60 R 18 43
PHENYTOIN SODIUM EXTENDED 160 75 18 17
CARBIDOPA-LEVODOPA 140 106 20 2
TRAZODONE HCL 138 66 21 31
PRIMIDONE 121 47 22 11
TIZANIDINE HCL 118 0 23 20
ROPINIROLE HCL 105 59 24 9
OXCARBAZEPINE 91 26 25 26
CYMBALTA 90 0 26 13
AMITRIPTYLINE HCL 89 37 R 27 14
PRAMIPEXOLE DIHYDROCHLORIDE 80 59 28 15
RISPERIDONE 79 45 29 57
PROMETHAZINE HCL 74 11 R 30 105
SUMATRIPTAN SUCCINATE 73 28 31 55
METHOCARBAMOL 70 24 R 32 66
COPAXONE 68 0 33 39
VIMPAT 67 0 34 19
HYDROXYCHLOROQUINE SULFATE 66 19 35 151
PROPRANOLOL HCL 66 25 35 30
GALANTAMINE HBR 61 61 37 36
CLOPIDOGREL 60 46 38 33
IMIPRAMINE HCL 59 36 R 39 114
MORPHINE SULFATE 57 0 S2 40 74
AVONEX 56 0 41 85
OPANA ER 54 23 S2 42 137
PYRIDOSTIGMINE BROMIDE 52 24 43 48
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on May 22, 2009.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.